Details of the Drug Reposition

General Information of This Drug (ID: DMBZK3P)

Drug Name	ISF35 DMBZK3P

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 2	[1]
Mantle cell lymphoma	DISFREOV	2A85.5	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00942409) Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Non-Hodgkin's Lymphoma (Follicular, Diffuse Large Cell, Mantle Cell, and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia. U.S. National Institutes of Health.